Novel mutation in the human HPRT1 gene and the Lesch-Nyhan disease

被引：9

作者：

Khue Vu Nguyen ^{[1
,2
]}

Naviaux, Robert K. ^{[1
,2
,3
]}

Nyhan, William L. ^{[2
]}

机构：

[1] Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, Dept Med Biochem Genet & Metab, Bldg CTF,Room C-103,214 Dickinson St, San Diego, CA 92103 USA

[2] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA

[3] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA

来源：

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2017年 / 36卷 / 11期

关键词：

Lesch-Nyhan disease; HPRT1; gene; HGprt enzyme; mutation; HND; epigenetics; epistasis; amyloid precursor protein; HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; AMYLOID PRECURSOR PROTEIN; EPIGENETIC REGULATION; DEFICIENCY; DISORDER; PHENOTYPE;

D O I：

10.1080/15257770.2017.1395037

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Lesch-Nyhan disease (LND) is a rare X-linked inherited neurogenetic disorder of purine metabolism in which the enzyme, hypoxanthine-guanine phosphoribosyltransferase (HGprt) is defective. The authors report a novel point mutation that led to HGprt-related neurological dysfunction (HND) in a family in which there was a missense mutation in exon 6 of the coding region of the HPRT1 gene: g. 34938G>T, c. 403G>T, p. D135Y. Molecular diagnosis is consistent with the genetic heterogeneity of the HPRT1 gene responsible for HGprt deficiency. It allows fast, accurate carrier detection and genetic counseling.

引用

页码：704 / 711

页数：8

共 50 条

[21] Generation of an iPSC line (SDQLCHi030-A) derived from PBMCs of a patient with Lesch-Nyhan syndrome caused by HPRT1 mutation
Li, Yue
Zhang, Huawei
Guan, Jingyun
Wang, Bin
Zhang, Haiyan
Liu, Yi
Gai, Zhongtao
STEM CELL RESEARCH, 2024, 74
[22] Lesch-Nyhan disease
Nyhan, W. L.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2008, 27 (6-7): : 559 - 563
[23] LESCH-NYHAN SYNDROME AND HPRT VARIANTS - STUDY OF HETEROGENEITY AT THE GENE LEVEL
SINGH, S
WILLERS, I
HELD, K
GOEDDE, W
PURINE AND PYRIMIDINE METABOLISM IN MAN VI, PT A: CLINICAL AND MOLECULAR BIOLOGY, 1989, 253 : 145 - 150
[24] Dopaminergic (mal-)development in absence of HPRT in Lesch-Nyhan disease
Visser, J. E.
Witteveen, J. S.
Van Boekel, W.
Jinnah, H. A.
Martens, G. J. M.
Kolk, S. M.
MOVEMENT DISORDERS, 2014, 29 : S35 - S36
[25] Carrier and prenatal diagnosis of Lesch-Nyhan disease due to a defect in HPRT gene expression regulation
Torres, Rosa J.
Garcia, Marta G.
Puig, Juan G.
GENE, 2012, 511 (02) : 306 - 307
[26] Lesch-Nyhan综合征8例临床特征及HPRT1基因变异分析
卢婷婷
陆相朋
廉文君
张尧
郑宏
杨艳玲
临床儿科杂志, 2023, 41 (12) : 931 - 936
[27] HPRT-mutations in Italian Lesch-Nyhan patients
Gathof, BS
Rocchigiani, M
Micheli, V
Gaigl, Z
Gresser, U
PURINE AND PYRIMIDINE METABOLISM IN MAN IX, 1998, 431 : 151 - 153
[28] Understanding the structure-function relationship of HPRT1 missense mutations in association with Lesch-Nyhan disease and HPRT1-related gout by in silico mutational analysis
Agrahari, Ashish Kumar
Priya, M. Krishna
Kumar, Medapalli Praveen
Tayubi, Iftikhar Aslam
Siva, R.
Christopher, B. Prabhu
Doss, C. George Priya
Zayed, Hatem
COMPUTERS IN BIOLOGY AND MEDICINE, 2019, 107 : 161 - 171
[29] Behavioral and cognitive characteristics of patients with Lesch-Nyhan disease and partial HPRT deficiency
Ward, J
Yun, J
Meyer, S
CLINICAL NEUROPSYCHOLOGIST, 2005, 19 (3-4) : 563 - 563
[30] Adenosine transport in HPRT deficient lymphocytes from Lesch-Nyhan disease patients
Torres, RJ
DeAntonio, I
Prior, C
Puig, JG
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (8-9): : 1193 - 1196

← 1 2 3 4 5 →